A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MU... von O'Cearbhaill, R.E., Park, J.H., Halton, E.F., Diamonte, C.R., Mead, E., Lakhman, Y., Kane, P., Riviere, I.C., Brentjens, R.J.

Volltext

Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs von Manley, C.A., Leibman, N.F., Wolchok, J.D., Rivière, I.C., Bartido, S., Craft, D.M., Bergman, P.J.

Volltext